Canopy, Cresco, Aurora and TerrAscend report; Wisconsin and Iowa leaders talk legalization; hemp THC deadlines near; DEA ...

Cresco Labs Q3 2026 earnings show $173M in revenue, a $14.5M net loss and $34.9M adjusted EBITDA, while operating profit ...

TerrAscend Q3 2026 revenue rose 4.8% to $68.2M, but operating income fell 7.7%. GAAP net loss reached $5.5M, while free cash ...

Canopy Growth Q2 FY2027 earnings show C$81.4M revenue, 141% international cannabis growth, shrinking gross margins and ...

Trulieve reports its first quarter after the Harvest deconsolidation, Green Thumb grows 11% and sits on $316 million in cash, ...

The April 23 order moving state-regulated medical cannabis to Schedule III raises the prospect of interstate commerce, but attorneys disagree on whether FDA approval is required first. A June 29 ...

NewLake Capital Partners reported $12M in Q3 revenue, $10.3M in adjusted FFO and $17.9M in cash, ending September with no ...

Green Thumb Q3 2026 revenue rose 11.3% to $324.4 million, with $316 million in cash, $58.3 million in operating cash flow and ...

Trulieve Q3 2026 revenue reached $230M with a 64% gross margin, $89M adjusted EBITDA and $327M cash following its NYSE ...

Europe’s entire legal cannabis market is smaller than Missouri’s, by one count. Seth Yakatan of Katan Associates says that’s ...

Cronos Q3 2026 revenue rose 75% to $63.5 million, with adjusted EBITDA up 201%, rapid growth in Germany and Israel, and a ...

Massachusetts voters keep adult-use sales, Idaho protects ballot access, Houston deprioritizes possession arrests and ...